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Background: Migrants from certain regions are at increased risk of key infectious diseases (including HIV,
tuberculosis (TB), hepatitis B and hepatitis C). Although guidelines increasingly recommend integrated
screening for multiple infections to reduce morbidity little is known about what migrants and healthcare
professionals think about this approach.
Methods: Prospective qualitative study in Leicester, United Kingdom within a novel city-wide integrated
screening programme in three iterative phases to understand views about infections and integrated screen-
ing. Phase 1 focus groups (nine) with migrants from diverse communities (n = 74); phase 2 semi-structured
interviews with healthcare professionals involved in the screening pathway (n = 32); phase 3 semi-struc-
tured interviews (n = 23) with individuals having tested positive for one/more infections through the pro-
gramme. Analysis was informed by the constant comparative process and iterative across phases 13.
Findings:Migrants’ awareness of TB, HIV and hepatitis B/C varied, with greater awareness of TB and HIV than
hepatitis B/C; perceived susceptibility to the infections was low. The integrated screening programme was
well-received by migrants and professionals; concerns were limited to data-sharing. As anticipated, given
the target group, language was cited as a challenge but mitigated by various interpretation strategies.
Interpretation: This large qualitative analysis is the first to confirm that integrated screening for key infectious
diseases is feasible, positively viewed by, and acceptable to, migrants and healthcare professionals. These
findings support recent guideline recommendations and therefore have important implications for policy-
makers and clinicians as programmes of this type are more widely implemented in diverse settings.
Funding: National Institute for Health Research.
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
(http://creativecommons.org/licenses/by-nc-nd/4.0/)Keywords:
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d. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)1. Introduction
Migration is an important determinant of population change
with increasing numbers of migrants arriving in Europe [1]; in 2017
over 4 million migrants arrived in the European Union (EU) with
half born in non-EU countries [1]. UK statistics indicate that
between 1991 and 2011, just over 150,000 migrants arrived in the
UK annually with 57.5% of migrants arriving from outside the EU
(31.7% from Africa and the Indian subcontinent) [2]. Estimates indi-
cate that 12.4% of the UK population are born overseas; over half of
these individuals originate from countries outside the UK and NorthAmerica [3]. Urban UK centres have higher levels of migration and
therefore larger overseas-born populations. For example, in Leices-
ter, approximately 30% of the population is born outside Europe and
North America, and individuals from the Indian subcontinent make
up 15% of the population making it one of the most diverse cities in
the UK [4].
Whilst migrants are a heterogeneous group [5,6], certain over-
seas-born individuals (particularly those from Africa and Asia) are at
an increased risk of, and disproportionately affected by, communica-
ble diseases - including tuberculosis (TB), HIV, hepatitis B and hepati-
tis C [5,7]. For example, overseas-born migrants account for over 70%
of UK TB notifications and have a 14-fold higher TB incidence than
UK-born individuals [8]. People born in Sub-Saharan Africa and
Southeast Asia are also at increased risk from blood-borne viruses
Research in context
Evidence before this study
Migrants from certain regions are at increased risk of key infec-
tious diseases (including HIV, tuberculosis (TB), hepatitis B and
hepatitis C). Early identification of these key infections can reduce
morbidity and mortality. Individual disease screening pro-
grammes have been implemented and shown to be acceptable to
migrants but there is limited data available on what migrants and
healthcare professionals think about integrated/combined infec-
tion screening programmes for multiple infections.
Added value of this study
Within the context of an ongoing migrant screening programme
this large qualitative study confirms that integrated screening for
multiple key infections is feasible, positively viewed by, and accept-
able to, migrants and healthcare professionals.
Implications of all the available evidence
Migrant screening programmes have historically been focused on
identifying individual infections. However this study has shown
that developing and delivering migrant screening programmes
which provide integrated screening for multiple key infections is
highly acceptable. These findings, therefore, support recent guide-
line recommendations and have important implications for policy-
makers and clinicians as programmes of this type are more widely
implemented in diverse settings.
2 H. Eborall et al. / EClinicalMedicine 21 (2020) 100315and account for significant proportions of newly diagnosed cases of
HIV and viral hepatitis [9,10].
Data on the outcomes from these communicable diseases suggest
that migrants are more likely to have adverse outcomes, including
late presentation to care [10,11], and more aggressive disease pro-
cesses [1013]; this therefore underscores the importance of early
diagnosis and management of communicable diseases in preventing
morbidity, mortality and onward transmission [14]. This position is
supported by several guidelines from the National Institute for Health
and Care Excellence (NICE) and other national/international bodies
which advocate screening for key infections [7] including active and
latent TB [15], HIV [16], hepatitis B and hepatitis C [17,18].
To date, clinical services (and associated research) have therefore
focused on identifying individual infections in migrants. Previous work
on these individual disease screening programmes has highlighted
that migrants are positive about screening for latent TB and viral hepa-
titis [19,20] but knowledge about key infections (including HIV) is
highly variable and may impact on screening uptake.
In response to the need for streamlining diagnostic pathways,
guidelines are increasingly advocating moving from individual dis-
ease screening to an integrated/combined infection screening
approach for multiple key infectious diseases where further assess-
ment and treatment is accessible, affordable and acceptable [7]. How-
ever, data supporting this programmatic approach is lacking perhaps
reflecting concerns about implementation and resource implications.
Moreover, there is no data on what migrants and healthcare profes-
sionals think about such an integrated screening approach. This is
critically important information for clinicians and policy-makers
developing and delivering migrant screening programmes.
In order to investigate this further we implemented a novel pri-
mary-care based programme of integrated migrant screening for
latent TB, HIV, hepatitis B and hepatitis C in Leicester, UK [21]. Within
the context of this integrated programme, we aimed to explore
migrants’ and healthcare workers’ views, concerns, needs and experi-
ences of an integrated infectious diseases screening programme.2. Methods
2.1. Ethics
This study received NHS Ethics and Health Research Authority
approval from East Midlands - Leicester South Research Ethics Com-
mittee (16/EM/0159). All participants gave written informed consent
prior to any study procedures.
2.1.1. Study setting and Leicester integrated migrant screening
programme
This study was conducted in Leicester, UK which is one of the
most ethnically diverse cities in the UK where an integrated migrant
screening programme for infectious diseases has been implemented.
The protocol for the Leicester integrated screening programme
has been described in detail previously [21]. Briefly, as part of routine
care, the national TB screening programme was modified so that new
migrants registering in primary-care who meet the eligibility criteria
for the programme (arrived in the UK within the last 5 years from a
country with TB incidence 150/100 000 or from sub-Saharan Africa
or are a refugee/asylum seeker) are offered integrated screening for
latent TB infection, HIV, hepatitis B and hepatitis C as part of a new
patient health-check. Individuals identified to have one/more of the
infections are referred to secondary-care infectious diseases special-
ists for further assessment and management.
2.2. Study design
This qualitative study involved three iterative, linked phases.
Findings from phase 1 (focus groups with members of migrant com-
munities) informed the subsequent phases. Findings from phases 2
and 3 (qualitative interviews with healthcare professionals and par-
ticipants who had experienced the screening and subsequent treat-
ment programme) overlapped and mutually informed the direction
of later stages of data collection and analysis in both phases.
2.3. Participants and recruitment
Phase 1: Focus group participants were individuals from a range of
migrant communities, typical to Leicester’s diverse population. We
liaised with local healthcare, third sector and educational organisa-
tions to purposively recruit groups of participants whose country of
origin matched eligibility criteria for the screening programme Nota-
bly, this included individuals who had attended or declined screen-
ing, and others who had not been invited to the screening
programme (such as those who been in the UK for longer than 5
years) in order to reach a wider sample within the target community
groups. We also worked with these organisations to purposively
sample for diversity in terms of country of origin, gender and age
whilst ensuring that participants would be representative of Leices-
ter’s migrant population. Focus groups took place in community-
based settings, including third sector organisations that work with,
and provide services for, migrants as well as educational settings
(providers of English for Speakers of Other Languages (ESOL) courses,
which attract many migrants).
Phase 2: Healthcare professional participants were individuals
working in healthcare - directly or indirectly involved in developing or
delivering the migrant screening and treatment pathway. We purpo-
sively sampled to reach a range in terms of professional role and type
of involvement with screening pathway. Recruitment of healthcare
professionals was via direct invitation, with an accompanying partici-
pant information leaflet, opt-in reply slip (to indicate willingness to be
contacted about the study) with pre-paid postage. Interviews with
healthcare professionals were conducted by telephone or in interview-
ees’ workplace (locations within primary care practices, Leicester City
Table 1a
Demographic characteristics of the focus group participants and those migrants
who were interviewed having undergone screening.
Demographic variable Focus group
participants (n = 74)
Individuals interviewed
having undergone
screening (n = 23)
Gender
Male 29 (39.1%) 12 (52.2%)
Female 45 (60.9%) 11 (47.8%)
Age, median (IQR) 33 (2939) 30 (2434)
World Bank region of birth
South Asia 30 (40.5%) 16 (69.6%)
Sub-Saharan Africa 43 (58.1%) 7 (30.4%)
Middle East and North Africa 1 (1.4%) 0 (0.0%)
English speaking 61/74 (82.4%) 22/23 (95.6%)
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(UHL) NHS Trust or Leicester City Council Public Health).
Phase 3: Interviews of participants who had been through the
screening programme. We purposively sampled individuals from
migrant communities who were eligible for, and had been through,
the Leicester integrated infectious diseases screening/treatment pro-
gramme who were typical of Leicester’s foreign-born population
(inclusion criteria were: age 16 years; arrival in the UK 5 years;
overseas-born; country of birth TB incidence 150/100 000 or sub-
Saharan Africa or Refugee/Asylum seeker. Migrants were recruited
from specialist infectious diseases clinics at University Hospitals
Leicester (UHL) NHS Trust. Individuals who met the inclusion criteria
were provided with verbal and written information about the study
(aided, if needed, by a member of staff who could translate). Individu-
als were given time to consider participation and the opportunity to
ask questions before the research assistant double-checked inclusion
and exclusion criteria and willingness to participate. Notably, the
interviewer did not know which disease/s they had tested positive
for; the interviewee could control how much to disclose. Interviews
took place in private research offices close to the Department of
Infection and HIV Medicine clinic at UHL Trust. Interviews were
mainly held in English except for one interview which took place
with an interpreter.
2.4. Study procedure, data collection, and management of data
Phase 1 Focus groups took place between November 2016 and
February 2017; they were moderated by trained qualitative research-
ers (JW assisted by KE/PU/MP), staff from the organisations and
translators (when needed). A flexible topic guide was used (see sup-
plementary information), which focused on awareness and experien-
ces of (any) health screening checks; (hypothetical) views about
attending the combined diseases screening programme; and aware-
ness of the four infectious diseases. Prior to the focus groups starting,
researchers took written informed consent, after taking time to
explain the study in full (aided by the key individuals and/or transla-
tors). Focus groups lasted, generally, for 60 min.
Phase 2 interviews (healthcare professionals) were conducted by
trained qualitative researchers(KE/FW) between January and July
2018. Phase 3 interviews (migrants who had been through (or were
going through) the screening and treatment pathway) were conducted
by trained qualitative researchers (KE/FW) between May 2017 and
March 2018. Interviews were generally held in English with inter-
preters if required and lasted for between 30 and 60 min. The
researcher took written informed consent immediately prior to all
interviews starting. Interviews were semi-structured and guided by a
flexible topic guide (see supplementary information) focusing on
views and experiences of the screening and treatment programme,
including feasibility issues. With participants’ consent, all focus groups
and interviews were audio-recorded and fully transcribed.
2.5. Data analysis
Analysis was informed by the constant comparative process [22]
and iterative across phases 13. Early Phase 1 transcripts were read
and discussed in analysis meetings (HE, JW, KE, MP, FW) to identify
preliminary themes and areas of interest to explore in greater depth
in subsequent focus groups. At the end of phase 1, themes and pat-
terns in the data were translated into an initial coding framework
(FW, HE); transcripts were coded (FW) with the framework (facili-
tated by QSR NVivo qualitative data-indexing software), which was
refined throughout the process. Findings from phase 1 influenced the
topic guides for phases 2 and 3. Phase 2 and 3 transcripts were read
and re-read (FW, HE), coded (FW) with the coding framework refined
regularly with new and amended themes. To ensure rigour and integ-
rity of analysis, HE reviewed the coding, and data summaries werediscussed in team meetings. Later in the process, charting (FW, HE)
was used to identify patterns [23,24].
When presenting the data, we refer to participants from migrant
communities as ‘participants’ in general, and at times distinguish
between ‘interviewees’ and ‘focus group participants,’ and healthcare
professional participants as ‘professionals’. We label data extracts
with a study ID number and for professionals we add a little informa-
tion about job role or department; overall we limit participant details
to ensure anonymity.2.6. Statistical analysis
We computed descriptive statistics for this study. Demographic
characteristics of the participants were summarised using median
and interquartile range (IQR) (for continuous variables) and propor-
tions/percentages (categorical variables).3. Role of funding
MP is supported by the National Institute for Health Research
(NIHR Post-Doctoral Fellowship, Dr Manish Pareek, PDF-2015-08-
102). The views expressed in this publication are those of the author
(s) and not necessarily those of the NHS, the National Institute for
Health Research or the Department of Health. Gilead Sciences pro-
vided an unrestricted grant to fund the cost of the blood-borne virus
tests but had no other involvement in the study. The funders had no
involvement in the analyses, writing of the manuscript or the deci-
sion to submit for publication.4. Results
4.1. Final sample
Overall we recruited 131 participants; one was deemed illegible
and thus withdrawn from the focus group before it started and one
withdrew themselves prior to their interview. This resulted in 129
study participants (see Tables 1a and 1b).
In phase 1, nine focus groups were conducted (total N = 74), with
participants who had been born in: Afghanistan, Bangladesh, Demo-
cratic Republic of the Congo, Eritrea, Ethiopia, Gambia, Ghana, India,
Iraq, Ivory Coast, Nigeria, Pakistan, Somalia and Sudan.
Our final phase 2 sample included 32 professionals from second-
ary care (N = 19), primary care (N = 9), public health (N = 2) and Clini-
cal Commissioning (primary care) (N = 2). Within this, there were
consultants and junior doctors in infectious diseases/respiratory
medicine (N = 10), nurses, including specialists in TB, HIV and inclu-
sion health (N = 8), healthcare assistants and specialist support work-
ers (N = 4), general practitioners (N = 5), managerial roles (N = 4) and
a medical laboratory scientist (N = 1).
Table 1b
Demographic characteristics and job roles of the healthcare professionals interviewed
in the study.
Demographic variable Healthcare professionals (n = 32)
Gender
Male 16 (50%)
Female 16 (50%)
Setting of work
Primary care 9 (28.1%)
Secondary care 19 (59.4%)
Public Health 2 (6.3%)
Clinical Commissioning Group 2 (6.3%)
Job role
Infectious Diseases/Respiratory/Hepatology
specialists
10 (31.3%)
Specialist nurses 8 (25%)
Healthcare assistant and specialist support
workers
4 (12.5%)
Primary care physicians 5 (15.6%)
Healthcare manager 4 (12.5%)
Laboratory scientist 1 (3.1%)
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in Afghanistan, Bangladesh, Cameroon, Eritrea, India, Nigeria, Paki-
stan, Somalia and Zimbabwe.
4.2. Awareness of infectious diseases and perceived risk
When asked about knowledge of the diseases prior to screening,
over half of interviewees reported awareness of TB and HIV, mention-
ing sources such as campaigns in their country of origin and a few
cases of relatives having TB. In general awareness of these conditions
was lower in some of the focus groups. Migrants’ knowledge of hepa-
titis B and C was very low across the sample.
“I never heard about hepatitis B in my life. I know about TB, but
hepatitis B I was like not aware of.” (Int. 018)
“I know TB but I didn’t know hepatitis [. . .] HIV I know because
[in] India we have some campaigns [. . .] and for TB also they are
doing some campaigns. . .” (Int. 020)
“. . .TB, HIV, and hepatitis B and C, some of the people don’t under-
stand actually [. . .] there’s a lack of knowledge, actually we don’t
know [. . .] what the disease [is] going to be and how can I like pre-
vent them [FG 009]
In terms of perceived risk, not one participant reported expecting
to test positive for HIV or hepatitis, and just three had considered
themselves possible candidates for TB due to past circumstances.
Low perceived risk was rooted in beliefs about candidacy (e.g. poor
immune systems), transmission (e.g. crowded living conditions for
TB and sexual behaviours for HIV) or having tested negative at previ-
ous screening (e.g. airport TB screening). Hence, those who tested
positive for one of the disease typically described being shocked.
“I was told I had latent TB. I was surprised, because before coming
to the country, I’ve already [had tests] done back home [and]
they’ve not shown anything.” (Int. 011)
“I was like, I am healthy, I am fine, so it might be something
regarding vitamins [. . .] and all of a sudden when I heard it is TB, I
got a bit lost [. . .] I got a bit shocked.” (Int. 027)
4.3. Views and experiences of combined infection screening
Participants often mentioned accepting and experiencing the tests
as part of a new patient general health check. The majority of thesespoke positively about the opportunity of being offered the tests rou-
tinely, citing benefits of prevention, particularly for asymptomatic
conditions, and/or that it was cost-free. In addition participants
highlighted the benefits of the combined programme testing for, and
potentially identifying, multiple infections at one time-point.
“Yeah, specifically, to register me for NHS [. . ..] and she took some
blood tests [. . .] it was for all of that, like TB, HIV and hepatitis and
everything.” (Int. 019)
“The screening [is] for Asians, Africans and people coming from
different selected countries [. . .] It’s good it’s free. But then if they
don’t turn up, how will they know it? Better safe than sorry [. . .]
it’s like when they come, do their full blood test at the very begin-
ning. You don’t have to wait for someone to have some problems,
start coughing or start sneezing.” (Int. 012)
A couple of focus group participants (who had not necessarily
been invited for screening) voiced reluctant to attend any testing
and/or engage with primary care:
“I’m scared to go to the GP, because I have got flatmates, they’re
going many times, and they’re taking a lot of bloods, but there’s
no result. If there’s not a result, just taking the blood, why should I
go to the doctors?” . . . [FG 002]
However, other participants, who recalled confusion about the
purpose of the testing and the reason for their invitation, later
acknowledged the benefits.
“[Participant] said he’s new in the city [. . .] he had a lot of [confu-
sion], [he] came from Africa, so he didn’t know exactly why they
are doing this. He was not happy as such, but he thought it’s better
to have this opportunity to know if I have any problem” (translat-
ing for focus group participant FG 001)
Professionals in the infectious diseases clinic were mindful of the
range of awareness and preparedness of patients attending, and the
likely associated reactions and emotions expressed.
“Some people will come with quite a good understanding of the
tests that have been done and they’ll be familiar with their results
[. . .] and they’ll have a clear idea of why they’ve come to see me
and what we’re going to discuss. Probably about a 50/50 split [. . .]
The other half will come and really not understand at all.” (H002,
TB service)
Professionals from across the pathway typically described the
combined screening approach as positive and efficient, mentioning
the benefits of early detection and treatment for the individual
patient and the population, with many predicting it to be cost-effi-
cient. Health professionals also cited the streamlining of services and
moving away from working in disease/infection silos and towards an
integrated programme.
“It’s kind of fabulous approach in preventative medicine, rather
than waiting for them to have TB, waiting for them to have hepati-
tis B, with its complications. Anticipate the right group of popula-
tion, pick them, screen them, follow them before they come
sick”. . . (H029, ID clinic)
“I think that’s absolutely brilliant, because that means patient
hasn’t got to come to practice again and again. [. . .] it’s saving
time to healthcare professionals as well as patients. So having this
kind of programme in place where you’re screening for more than
one condition definitely is good. I mean obviously you’re only tak-
ing one set of blood as well, at the same time. . .” (H001, Clinical
Commissioning)
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Some healthcare professionals voiced concern about perceived
victimisation and stigmatisation, if the programme was seen as
directly targeting particular groups due to assumptions made about
their country or origin and associated behaviours or lifestyles with
negative connotations
“You could feel like insinuations were being made about your life-
style couldn’t you, which could feel very uncomfortable, it could
actually be quite upsetting.” (H027, Public Health)
“There’s huge issues around stigma. . . how would you feel, you’re
resettling, you’re trying to get into a new community and we say,
‘oh, actually, if you come from here, you’re fine; if you come from
there, we need to screen you’? (H016, Public Health)
Notably, with the exception of a nurse who reported occasional
patients saying they felt “a bit picked on” such concerns were voiced
by professionals that are in non-patient-facing roles. Indeed, those
with patient contact emphasised the importance of talking about IDs
without apprehension in order to minimise (rather than exacerbate)
any stigmatisation associated with the conditions and/or testing:
“I think if you tiptoe around something, then the patient them-
selves feel that disease has to be tiptoed around and [. . .] you can
actually make something more secretive and more stigmatised
than it was in the first place.” (H023, TB service)
Indeed, for the participants, it was less a sense of stigmatisation
from being targeted for disease screening, but more an unease about
how the data collected would be stored and used. For example, some
feared implications for immigration and/or asylum applications if
testing positive of one or more conditions.
“Most of [fellow focus group participants] are not here as British
citizen, they didn’t come British citizen. Their fear is what [will]
happen to my [visa/citizenship] case if I’ve got these diseases,
they might be rejecting me from the country, they might close my
case” (FG 007)
Several professionals discussed anticipation of such concerns and
their keenness to allay newmigrants’ fears by developing a good rela-
tionship with them and conveying the benefits of treatment.
“I think just the most important thing is to sort of let the migrant
understand that [. . .] if they’re found to be positive then it’s some-
thing that we can treat and they’re not going to be sent out of Eng-
land or not allowed to work. And I think that’s- it’s building up
trust, a lot of it is trust.” (H003, TB service)4.5. Receiving test results and treatment
Most participants who had experienced the screening and treatment
described, or indicated, an overall positive experience of the pro-
gramme. Participants highlighted instances in clinic when professionals
had taken time to explain the disease diagnosed, its transmission and
treatment/monitoring regime(s), which gave participants reassurance
and/or a sense of feeling fully informed and reduced anxiety.
“I’m shocked [. . .] I’m searching Internet, what happened? Still
confused. Then after [the doctor explained] my tension is gone
away and I think because he told me like that, in three months
you will be alright.” (Int. 010)
“He’s giving me the tablet[s] step by step. First previously he had
not given me the TB one, he had just started for me the hepatitis Bmedicine, because the units have to be decreased. So once it gets
decreased then he’s going to start me a TB medicine” (Int. 018)
Some professionals interviewed had specific roles relating to fol-
lowing-up and checking patient understanding, acknowledging the
benefit of this dedicated time. Indeed, participants mentioned reas-
surance from follow-up care provided.
“[The nurse] came to my house, one, two times. To check me, how
I am [. . .] when I’m starting my medicine. After she come to me
like one week and two days. [. . .] she checked my medicines, my
timetable.” (Int. 010)
A few participants recalled being anxious, following initial testing
in primary care; for a couple this was due to their uncertainty about
when and how they would receive their results. In one case, friends
with more familiarity with the healthcare system explained:
“. . .after the test, he was a bit worried, but he asked one of his
friends. They [said], ‘After doing the test, if there’s anything wrong
then you’ll get a letter. So if you haven’t received anything then
you’re OK.’” (translating for focus group participant FG 001)
For a few others, the wait between testing positive and awaiting
treatment was the most worrying point. A potential source of confu-
sion in the early stages related to the terms ‘positive’ and ‘negative’
regarding test results.
“If it’s positive [it] means everything’s fine,..no, sorry, if negative,
everything is fine, I think.”
(Moderator: But that’s interesting that you said that. I mean did, is
that, was your thoughts before you came here that if it was negative that
meant you had HIV?)
“negative is positive. Yeah, sometimes I become confused.”
(FG 009)
Both participants and professionals mentioned language as a key
challenge in ensuring full understanding, particularly given the num-
ber of different languages spoken by patients. Strategies for address-
ing this included employing multilingual cultural link workers,
accessing interpreters and some healthcare professionals spoke in a
patient’s language.
“There is such a wide variety of nationalities and languages and
many of our patients don’t speak English particularly well. We do
have some people in the TB service that speak foreign languages,
like mainly Indian languages, but they don’t speak some of the
African languages and we have to use [telephone interpreting ser-
vice] which isn’t always ideal.” (H018, ID clinic)
Professionals acknowledged that access to such services was more
difficult for primary care, leading to challenges at the time of the ini-
tial test, although this could be addressed for those testing positive
once in clinic.
“Sometimes GPs might, you know, write and say it was difficult
having a conversation with them because of language barriers
and so [we] end up having to have a lot more detailed conversa-
tion with some of them.” (H013, ID clinic)
5. Discussion
We undertook a large qualitative study within an ongoing inte-
grated infectious diseases migrant screening programme in the UK
[21] to understand, for the first time, the views of migrants and
6 H. Eborall et al. / EClinicalMedicine 21 (2020) 100315healthcare professionals to combining screening for multiple key
infectious diseases including latent TB, HIV, hepatitis B and hepatitis
C. Our rigorous analysis has highlighted elements relating to accept-
ability of screening interventions thereby providing information for
clinicians and policy-makers developing public health programmes
for migrants.
We found that both migrants and healthcare professionals had
positive views about the integrated screening programme. Staff and
migrant participants mentioned the benefits of early prevention and
treatment; staff commended its efficiency; and participants appreci-
ated the care received (including time taken to explain diagnosis and
treatment) and lack of cost. Our findings are in keeping with previous
work on individual disease testing programmes [19,20] but our work
extends the evidence base by documenting, for the first time, the pos-
itive opinions to integrated/combined infection disease screening for
TB, HIV and viral hepatitis thereby providing empirical data to sup-
port recent ECDC guidelines which recommend moving from single/
individual disease testing to integrated multiple infection screening
[7]. This finding is critically important when designing real-world
screening programmes which improve access to testing for serious
infections in one visit (rather than multiple visits) and also limit attri-
tion through the cascade of care [25].
Concerns about screening triggering stigmatisation of migrants
appear to be unfounded; rather, participants raised concern about
test results impacting on immigration and/or asylum applications.
Professionals who worked closely with those being treated were
keen to allay such concerns by building trusting relationships. Impor-
tantly, issues relating to stigma around the infectious diseases was
not prominent in this cohort. This finding is in keeping with recent
research on TB in the UK [26] and may reflect the fact that the study
participants were, generally, a younger group who may have had
more exposure to disease control programmes/education in their
countries of origin prior to migration or that they had more concerns
about the fear of implications for immigration/asylum. Additionally,
although we did not find religion or cultural taboo as prominent
themes influencing screening uptake in our cohort, previous work
relating to testing for hepatitis B did find that it did affect screening
participation [27,28].
We found that migrants’ awareness of the four infectious diseases
varied, with greater awareness of TB and HIV, than hepatitis B and C.
There was a tendency towards low personal perceived risk, and those
who had tested positive for one of the diseases reported being
shocked. Previous studies examining individual infections have also
demonstrated that migrants have limited awareness of certain infec-
tions and typically low perceived susceptibility across all conditions
which may adversely impact on screening uptake [2933]. However,
this study adds to the evidence base as participants in our study were
asked about all four key infections which allowed us to explore com-
parative perceptions within one study. The findings indicate a need to
raise awareness of all four key infections, including transmission
methods, risk factors (relating to country of birth and migration route)
and the availability of treatment prior to an individual’s invitation to
testing. Hence, our study adds to calls from prior research for
improved public-facing awareness-raising programmes, which
acknowledge and address perceptions of target group and local con-
text. Any such awareness campaigns will need to take into account
multiple factors including migrants’ country of origin, age, gender, lan-
guage skills and educational attainment [34]. Further, we extend this
argument by recommending a method for doing this on a local level:
our methodological approach of recruiting and conducting focus
groups in liaison with local community organisations, revealed that
many new migrants consult these organisations before engaging with
healthcare, hence identifying useful  and novel  settings for under-
taking awareness raising about infectious diseases and availability of
(free) healthcare services.Participants’ experiences highlighted points in the pathway when
there may be raised anxiety (e.g., awaiting test results) and/or confu-
sion (whether or not negative results would be communicated as
well as positive ones). Finally, the demographics of new migrants
invited to this programme mean that language is often an influence
on full communication. It is important, therefore, that culturally com-
petent healthcare is the focus of such screening programmes.
Although this can include various strategies [35], such as interpreters,
visual material and linguistic matching in our programme we found
that investing in roles such as a ‘multicultural link worker’, healthcare
professionals having the ability to speak some languages in common
with migrant communities and developing resources in some lan-
guages have improved communication between migrants and
healthcare professionals.
On a practical level, our work has shown that the provision of sim-
ple information (in written form or as an online resource) at the out-
set should include key points about the process for receiving results
and who will/will not have access to results. In terms of language,
while the pros and cons of strategies for translation are well-docu-
mented (for example, use of interpreters [36], providing understand-
able information for patients in some format should remain a priority
for services likely to be used by new migrants. A review of the lan-
guages spoken by users of a service can guide both the development
of documentation and resources, and inform services about useful
languages for multicultural link workers to be proficient in.
Migrants are often an underserved and unheard group in research
and clinical studies. However, we argue that a particular strength of
this study is the size and diversity of the sample as well as the fact
that it was representative of the foreign-born population and those
screened/treated through the screening programme; it includes indi-
viduals born in 16 different countries, 23 of whom were receiving
treatment after having tested positive for at least one disease through
the programme, and professionals involved at all stages of this novel
testing and treatment pathway. One disadvantage of the diversity of
country of origin is the difficulty of exploring cultural differences
between participants in full (given the small numbers from some
countries). Although our cohort was large and covered the testing
and treatment pathway, we anticipated that gaining the perspectives
of individuals who did not attend the combined testing or an even
larger number of individuals who tested negative for the infections in
primary care would be challenging ethically and practically. The
phase 1 focus groups aimed to address this, by seeking views of a
wider sample, and within these groups we were able to better under-
stand any concerns relating to screening for infection  some of
whom had already been through the screening programme.
Unsurprisingly, given the target participant group, limited English
language restricted the extent to which some participants could
express themselves (particularly in the phase 1 focus groups). We
sought to mitigate this as much as possible by undertaking focus
groups in liaison with third sector and educational organisations,
where often interpreters (formal or informal) could assist, but we
acknowledge the limitations nonetheless. Our work focused on youn-
ger individuals who make up the largest group of migrants arriving in
the UK (and Leicester) [37] but future work should also prospectively
recruit older migrants and within migrant subgroups in other geo-
graphical settings who may have different views and levels of knowl-
edge relating to infection and screening.
In conclusion, we found that an integrated infectious disease
screening programme for migrants was feasible and acceptable to
members of the target group as well as healthcare professionals
involved in the development and delivery of the pathway of care.
Our findings support the recommendations made in recent guide-
lines and have important implications for policy-makers and clini-
cians as further programmes of this type are developed and
implemented in an increasing number of geographical settings.
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